GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Sipai Health Technology Co, 314.HK · HKD

Consumer Staples · HKEX · 🇭🇰 Hong Kong

Compare

1.38

0.00%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2024

Revenue

CN¥4.57bn

FY2020FY2024

Net income

−CN¥323.7m

FY2020FY2024

Free cash flow

−CN¥70.2m

FY2020FY2024

Shareholders' equity

CN¥1.23bn

FY2020FY2024

Income statement

Fiscal years

FY2024FY2023FY2022FY2021FY2020
RevenueCN¥4.57bnCN¥4.71bnCN¥4.12bnCN¥3.47bnCN¥2.70bn
Gross profitCN¥385.5mCN¥412.5mCN¥334.0mCN¥281.1mCN¥183.6m
Research and developmentCN¥22.3mCN¥45.9mCN¥62.6mCN¥59.2mCN¥45.7m
Operating income−CN¥248.8m−CN¥249.7m−CN¥623.3m−CN¥707.2m−CN¥411.9m
Net income−CN¥323.7m−CN¥255.8m−CN¥1.37bn−CN¥3.74bn−CN¥1.04bn
Diluted earnings per share-0.51-0.34-1.80-4.90-1.37

Balance sheet

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020
Total assetsCN¥2.27bnCN¥2.82bnCN¥2.93bnCN¥2.89bnCN¥2.48bn
Cash and short-term investmentsCN¥919.8mCN¥1.13bnCN¥1.53bnCN¥1.61bnCN¥1.67bn
Total liabilitiesCN¥1.04bnCN¥1.20bnCN¥1.09bnCN¥8.32bnCN¥4.28bn
DebtCN¥45.5mCN¥67.6mCN¥67.8mCN¥7.52bnCN¥3.68bn
Shareholders' equityCN¥1.23bnCN¥1.62bnCN¥1.84bn−CN¥5.43bn−CN¥1.80bn
Shares outstanding639m762m763m763m763m

Cash flow

Fiscal years

FY2024FY2023FY2022FY2021FY2020
Cash from operations−CN¥59.4m−CN¥133.5m−CN¥182.1m−CN¥621.9m−CN¥192.1m
Capital spending−CN¥10.7m−CN¥5.7m−CN¥11.8m−CN¥21.4m−CN¥14.7m
Free cash flow−CN¥70.2m−CN¥139.2m−CN¥193.9m−CN¥643.3m−CN¥206.8m
Dividends paid—−CN¥1.5m———

Latest quarters

By quarter end

Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022Jun 2022Dec 2021
RevenueCN¥1.22bnCN¥2.20bnCN¥2.36bnCN¥2.27bnCN¥2.44bnCN¥2.23bnCN¥1.89bnCN¥1.92bn
Gross profitCN¥176.1mCN¥157.5mCN¥228.9mCN¥196.6mCN¥218.1mCN¥159.7mCN¥174.2mCN¥164.0m
Operating income−CN¥78.1m−CN¥245.9m−CN¥88.2m−CN¥169.3m−CN¥111.7m−CN¥352.0m−CN¥264.1m−CN¥352.4m
Net income−CN¥72.0m−CN¥245.5m−CN¥78.2m−CN¥163.4m−CN¥92.3m−CN¥1.02bn−CN¥346.3m−CN¥1.23bn
Diluted earnings per share-0.12-0.39-0.12-0.19-0.14-1.34-0.45-1.61
Total assetsCN¥1.83bnCN¥2.27bnCN¥2.92bnCN¥2.82bn—CN¥2.93bnCN¥2.91bn—
Cash and short-term investmentsCN¥597.9mCN¥919.8mCN¥955.1mCN¥1.13bn—CN¥1.53bnCN¥1.37bn—
DebtCN¥10.8mCN¥25.8mCN¥37.1mCN¥41.3m—CN¥38.7mCN¥7.96bn—
Shareholders' equityCN¥995.9mCN¥1.23bnCN¥1.50bnCN¥1.62bn—CN¥1.84bn−CN¥6.06bn—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue9.5%——
Operating income-29.4%——
Net income-55.8%——

Average margins

Over each period

1 year3 years5 years10 years
Gross margin8.6%8.4%——

Valuation history

At each fiscal year end

FY2024FY2023FY2022
Price to earnings-9.2-17.6-5.3
Price to sales0.71.01.8

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.